RecruitingNot ApplicableNCT06402942

Gamified Occupational Therapy for Adolescents With Duchenne Muscular Dystrophy


Sponsor

Başak Çağla Arslan

Enrollment

20 participants

Start Date

May 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This research aims to improve the quality of life, occupational performance, occupational satisfaction and emotional health of young people with Duchenne muscular dystrophy compared to the classical occupational therapy program. The findings are planned to shed light on the development of new and effective strategies in the rehabilitation of adolescents with Duchenne muscular dystrophy.


Eligibility

Sex: MALEMin Age: 13 YearsMax Age: 18 Years

Inclusion Criteria5

  • Being diagnosed with Duchenne muscular dystrophy
  • To be literate in Turkish
  • To have scored 27 points or more on the Modified Mini Mental Test
  • Having a computer, tablet and internet connection
  • Volunteering to participate in the study by their parents and reading and signing the informed consent form

Exclusion Criteria3

  • Having a neurological disease other than Duchenne muscular dystrophy and/or another diagnosed neurological disease accompanying Duchenne muscular dystrophy
  • Having a cooperation problem that prevents completing the assessments for any reason
  • Difficulty understanding and speaking the Turkish language

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERGamified occupational therapy programme

Gamified occupational therapy program for the experimental group and classical occupational therapy program for the control group, which will be applied to both groups for eight weeks

OTHERClassic occupational therapy programme

Gamified occupational therapy program for the experimental group and classical occupational therapy program for the control group, which will be applied to both groups for eight weeks


Locations(1)

Lokman Hekim University

Ankara, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06402942


Related Trials